The commitment will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple ...

Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A in the bio/pharmaceutical industry and the struggle small biotech companies face raising funds.